Gene: MED14OS
Official Full Name: MED14 opposite strandprovided by HGNC
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO16262 | MED14OS Knockout cell line (HeLa) | Human | MED14OS | 1:3~1:6 | Negative | Online Inquiry |
KO16263 | MED14OS Knockout cell line (HCT 116) | Human | MED14OS | 1:2~1:4 | Negative | Online Inquiry |
KO16264 | MED14OS Knockout cell line (HEK293) | Human | MED14OS | 1:3~1:6 | Negative | Online Inquiry |
KO16265 | MED14OS Knockout cell line (A549) | Human | MED14OS | 1:3~1:4 | Negative | Online Inquiry |
MED14OS Gene Knockout Cell Lines are engineered cell lines that have undergone specific gene-editing techniques to create targeted knockouts of the MED14 gene. This gene encodes a subunit of the Mediator complex, which is crucial for the transcriptional regulation of various genes. The knockout cell lines offer a unique platform for studying the functional implications of MED14 in cellular processes such as gene expression, cell signaling, and response to external stimuli.
These cell lines work by employing advanced CRISPR-Cas9 technology, which allows for precise modifications in the genome. By disrupting the MED14 gene, researchers can gain insights into how its absence affects cellular functions, potentially revealing its roles in pathways associated with diseases like cancer, metabolic disorders, and neurodegenerative conditions. This ability to create a controlled genetic deficiency makes MED14OS Gene Knockout Cell Lines invaluable in both research and therapeutic contexts, offering a means to explore the mechanistic pathways that underpin complex biological phenomena.
The scientific importance of MED14OS cell lines extends to their applications in drug discovery, target validation, and the elucidation of gene function. They serve as powerful tools for understanding gene-disease relationships, making them essential for both academic research and the biotechnology industry. Compared to traditional knockout models, these engineered cell lines provide quicker, more reproducible results, thereby accelerating the pace of discovery.
Researchers and clinicians can greatly benefit from the precise gene-editing capabilities of MED14OS cell lines, enabling them to explore new therapeutic avenues more efficiently. The unique advantage of using cell lines that embody cutting-edge gene-editing technology lies in their reliability and versatility, catering to a broad spectrum of research needs.
Our company prides itself on its commitment to quality and innovation in the field of genetic engineering. With robust expertise in developing and supplying advanced biological products, we provide researchers with the essential tools they need to drive scientific advancements. MED14OS Gene Knockout Cell Lines exemplify our dedication to enhancing research capabilities and enabling discoveries that have the potential to transform clinical practice.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.